Loading…
Loading…
TECH · NASDAQ · Healthcare
“With a P/E ratio approaching 100 and minimal earnings per share, this biotechnology tools company trades at valuations that offer no discernible margin of safety.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$7.92B
P/E Ratio
97.61
Forward P/E
—
EPS
$0.24
PEG Ratio
10.74
Book Value
$12.90
Dividend Yield
0.16%
Profit Margin
12.85%
ROE
1.89%
Use the interactive ipo calendar with pre-loaded data for Bio-Techne Corp. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for TECH: